Drugs / E. coli Nissle suspension
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02706184 | Jul 2015 → Jan 2018 | colorectal cancer, gastric cancer | University of Hohenheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E. coli Nissle suspension | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02706184 ↗ |
| Known as | EcN | “Escherichia coli Nissle 1917 (EcN) is a well investigated probiotic.” NCT02706184 ↗ |